Clinical Trial Update: Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the integration of buprenorphine treatment into HIV primary care settings to manage opioid use disorder in people with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Yale University | Conditions: Buprenorphine, HIV | Phase 4 | Status: COMPLETED